Literature DB >> 29488180

First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.

Rogelio de J Treviño-Rangel1, José F Espinosa-Pérez1, Hiram Villanueva-Lozano1, Alexandra M Montoya1, Angel Andrade1, Alexandro Bonifaz2, Gloria M González3.   

Abstract

Candida bracarensis is an emerging cryptic species within the Candida glabrata clade. To date, little is known about its epidemiology, virulence, and antifungal susceptibility. This study documents the occurrence of C. bracarensis for the first time in Mexico and focuses on its in vitro production of hydrolytic enzymes, as well as antifungal susceptibility to echinocandins. This strain was isolated from a vaginal swab of a female with vulvovaginal candidosis; exhibited a very strong activity of aspartyl proteinase, phospholipase, and hemolysin; and was susceptible to caspofungin, anidulafungin, and micafungin (MIC = 0.031 μg/mL). Data obtained could contribute to the knowledge of the epidemiology and virulence attributes of this yeast as a fungal opportunistic human pathogen.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29488180     DOI: 10.1007/s12223-018-0592-5

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  47 in total

1.  Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.

Authors:  Julia Alcoba-Flórez; Sebastián Méndez-Alvarez; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; María del Pilar Arévalo
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.

Authors:  Shin-ichi Fujita; Yasuko Senda; Tikako Okusi; Yumi Ota; Hideaki Takada; Kazunori Yamada; Mitsuhiro Kawano
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

3.  Phenotypical characterization and molecular identification of clinical isolates of Candida tropicalis.

Authors:  Rogelio de J Treviño-Rangel; Byron A Bodden-Mendoza; Alexandra M Montoya; Hiram Villanueva-Lozano; Mariana Elizondo-Zertuche; Efrén Robledo-Leal; Gloria M González
Journal:  Rev Iberoam Micol       Date:  2017-12-26       Impact factor: 1.044

4.  Esterase activity of Candida species isolated from immunocompromised hosts.

Authors:  Chethrapilly Purushothaman Girish Kumar; Thangam Menon; Thangavel Sundararajan; Sarathy Nalini; Mandayam Anandampillai Thirunarayan; Sikhamani Rajasekaran; Manjetti Venkatadesikalu
Journal:  Rev Iberoam Micol       Date:  2006-06       Impact factor: 1.044

5.  Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.

Authors:  Cheshta Sharma; Sandeep Wankhede; Sumathi Muralidhar; Anupam Prakash; Pradeep K Singh; Shallu Kathuria; Deepa Anil Kumar; Nilofar Khan; Harbans S Randhawa; Jacques F Meis; Anuradha Chowdhary
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-26       Impact factor: 2.803

6.  Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.

Authors:  E Girão; A S Levin; M Basso; S Gobara; L B Gomes; E A S Medeiros; S F Costa
Journal:  Med Mycol       Date:  2008-09       Impact factor: 4.076

Review 7.  Vulvovaginal candidosis.

Authors:  Jack D Sobel
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

8.  Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.

Authors:  Andrew M Borman; Rebecca Petch; Christopher J Linton; Michael D Palmer; Paul D Bridge; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

9.  Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael Gherna; Justin A Bishop; William G Merz; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

10.  Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.

Authors:  Arnaldo L Colombo; Thais Guimarães; Teresa Sukienik; Alessandro C Pasqualotto; Ricardo Andreotti; Flavio Queiroz-Telles; Simone A Nouér; Marcio Nucci
Journal:  Intensive Care Med       Date:  2014-08-01       Impact factor: 17.440

View more
  4 in total

1.  Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.

Authors:  Mohammad Asadzadeh; Ahlam F Alanazi; Suhail Ahmad; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

2.  Usefulness of a multiplex PCR for the rapid identification of Candida glabrata species complex in Mexican clinical isolates.

Authors:  María Del Rocío Reyes-Montes; Gustavo Acosta-Altamirano; Esperanza Duarte-Escalante; Eduardo García Salazar; Erick Martínez-Herrera; Roberto Arenas; Gloria González; María Guadalupe Frías-De-León
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-08-08       Impact factor: 1.846

3.  Rapid identification of the Candida glabrata species complex by high-resolution melting curve analysis.

Authors:  Shuqian Cai; Juan Xu; Yakun Shao; Jie Gong; Fei Zhao; Lihua He; Xiaoyun Shan
Journal:  J Clin Lab Anal       Date:  2020-02-11       Impact factor: 2.352

4.  Candida bracarensis, an emerging yeast involved in human infections.

Authors:  S Mormeneo Bayo; M P Palacián Ruíz; R M Martínez Álvarez; C López Gómez; S Loscos Aranda; M C Villuendas Usón
Journal:  Rev Esp Quimioter       Date:  2021-07-05       Impact factor: 1.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.